4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-22-018749
10% owner bought 2,850,000 shares at $10.00 ($28,500,000)
- 10% owner acquired 2,785,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chen Bihua 10% owner | 2022-04-05 | Conversion | +2,785,000 | 3,215,000 | I | ||
| Chen Bihua 10% owner | 2022-04-05 | Purchase | +2,850,000 | $10.00 | $28,500,000 | 2,850,000 | I |
| Derivatives | |||||||
| Chen Bihua 10% owner | 2022-04-05 | Conversion · Class B Ordinary Shares | −2,785,000 | 0 | I | ||
| Open-market purchases · 2,850,000 sh · avg $10.00 · $28,500,000 | |||||||
Loading xslF345X03/ownership.xml…